Determination of cardiac disease biomarker by plasmonic sandwich ELISA

Weirong Wei1, Yinyan Tang2, Huimin He2

  • 1Department of Cardiology, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, People's Republic of China.

Insights

A novel plasmonic enzyme-linked immunosorbent assay (ELISA) enables rapid, bare-eye detection of C-reactive protein (CRP). This method aids in diagnosing acute myocardial infarction (AMI) by quantifying CRP levels more easily.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Biochemistry

Background:

  • Acute myocardial infarction (AMI) is a critical condition caused by interrupted blood flow to the heart muscle.
  • Elevated C-reactive protein (CRP) levels are a significant indicator in AMI patients, with temporal variations observed in plasma.
  • Accurate quantification of CRP is crucial for identifying conditions associated with AMI.

Purpose of the Study:

  • To develop a sensitive and accessible method for quantifying C-reactive protein (CRP) for acute myocardial infarction (AMI) diagnosis.
  • To utilize plasmonic enzyme-linked immunosorbent assay (ELISA) for bare-eye detection of CRP.

Main Methods:

  • A plasmonic ELISA was employed using an aptamer-antibody sandwich to detect CRP.
  • Gold nanoparticle aggregation, indicated by a blue color change, was used for bare-eye CRP detection.
  • Hydrogen peroxide (H2O2) concentration and catalase presence on the ELISA surface controlled gold growth and color differentiation.

Main Results:

  • Optimal conditions for lowest detection limit involved H2O2 (200 µM), gold seed (0.2 µM), and streptavidin-catalase (1:500).
  • A detection limit of 0.25 µg/mL was achieved in buffer and 0.5 µg/mL in CRP-spiked serum.
  • The assay demonstrated a clear color change (blue for aggregation, red for dispersion) for visible CRP detection.

Conclusions:

  • The developed plasmonic ELISA offers a simplified and effective approach for CRP level detection.
  • This method facilitates easier diagnosis of AMI by providing a rapid and visual assessment of CRP concentrations.

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
16.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
353
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
570